Literature DB >> 26808786

Patient reported outcome measures in chronic obstructive pulmonary disease: Which to use?

Magnus Ekström1, Josefin Sundh2, Kjell Larsson3.   

Abstract

Patient-reported outcomes (PROs), such as symptoms and perceived health status, are essential in chronic obstructive pulmonary disease (COPD) for determining disease severity, impact on daily life, effect of treatment and recovery from exacerbations. This field has evolved rapidly and there are a plethora of instruments assessing different PROs. The aim of this review is to provide an understanding of the concept of PROs in COPD. The PROs reflect important aspects of COPD which have a direct impact on daily life. Common symptoms such as dyspnea, cough, phlegm, anxiety, fatigue, and pain and as well as physical function and the risk for and occurrence of acute exacerbations should be assessed both in the clinic and in research. Besides impact on daily life, some of the PROs are related to disease progress and mortality. Construction of composite variables including different disease specific and generic PROs provide a general estimation of health status.

Entities:  

Keywords:  COPD; Dyspnea; Exacerbation; Health status; Measurement; PROM; Quality of Life

Mesh:

Year:  2016        PMID: 26808786     DOI: 10.1586/17476348.2016.1146595

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  8 in total

1.  Swedish translation and linguistic validation of the multidimensional dyspnoea profile.

Authors:  Magnus Ekström; Josefin Sundh
Journal:  Eur Clin Respir J       Date:  2016-11-08

2.  Genetic profile and patient-reported outcomes in chronic obstructive pulmonary disease: A systematic review.

Authors:  Hélder Melro; Jorge Gomes; Gabriela Moura; Alda Marques
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

3.  Comparison between electronic and paper versions of patient-reported outcome measures in subjects with chronic obstructive pulmonary disease: an observational study with a cross-over administration.

Authors:  Koichi Nishimura; Masaaki Kusunose; Ryo Sanda; Yousuke Tsuji; Yoshinori Hasegawa; Toru Oga
Journal:  BMJ Open       Date:  2019-12-18       Impact factor: 2.692

4.  Psychometric validation of the Korean Patient-Reported Outcome Measurement Information System (PROMIS)-29 Profile V2.1 among patients with chronic pulmonary diseases.

Authors:  Danbee Kang; Jihyun Lim; Bo-Guen Kim; Heesu Nam; Youngha Kim; Eunjee Kang; Sooyeon Kim; Sungkeun Shim; Mangyeong Lee; Junghee Yoon; Hyun Lee; Sun Hye Shin; Hye Yun Park; Juhee Cho
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 2.895

5.  Are in Person and Telephone Interviews Equivalent Modes of Administrating the CAT, the FACIT-FS and the SGRQ in People With COPD?

Authors:  Vânia Rocha; Cristina Jácome; Vitória Martins; Alda Marques
Journal:  Front Rehabil Sci       Date:  2021-10-25

6.  Dyspnea could be accurately assessed by a caregiver in hospitalized patients with respiratory diseases: Interrater reliability and agreement study.

Authors:  Gregory Reychler; Marc Beaumont; Anne-Claire Latiers; Thierry Pieters; Antoine Fremault
Journal:  Braz J Phys Ther       Date:  2021-05-24       Impact factor: 3.377

Review 7.  Patient-Reported Outcomes (PROs) in COPD Clinical Trials: Trends and Gaps.

Authors:  Nuzhat Afroz; Florian S Gutzwiller; Alex J Mackay; Christel Naujoks; Francesco Patalano; Konstantinos Kostikas
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-23

8.  Is the St. George's Respiratory Questionnaire an Appropriate Measure of Symptom Severity and Activity Limitations for Clinical Trials in COPD? Analysis of Pooled Data from Five Randomized Clinical Trials.

Authors:  Angely Loubert; Antoine Regnault; Juliette Meunier; Florian S Gutzwiller; Stéphane A Regnier
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-09-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.